ABSTRACT. The aim of this study was to explore the relationship between adiponectin (ADPN) and hemorrhagic shock (HS) and the recovery after HS. This is significant for further understanding of the pathophysiological processes of HS and the development of better treatments. In total, 72 male C57BL/6 mice were assigned randomly to three groups: control, HS, and recovery (N = 24). The HS mouse model was constructed by hemorrhage of the carotid artery and recovery was achieved by tail vein injection of Ringer's solution. The level of ADPN in the peripheral blood of mice before and after recovery was detected by enzyme-linked immunosorbent assay. Compared to control, HS mice showed significantly decreased ADPN levels with the extension of HS time while the level of ADPN in recovery mice increased significantly and remained high. The variation of ADPN levels was closely associated with the occurrence of HS in mice and their recovery, suggesting that ADPN might act as a biomarker of inflammation and have potential for the treatment of HS.
INTRODUCTION
Hemorrhagic shock (HS) refers to shock caused by a large amount of blood loss and is commonly seen in trauma-induced bleeding, peptic ulcer hemorrhage, esophageal variceal bleeding, and bleeding caused by obstetrical and gynecological diseases (Determan Jr. et al., 2014; Luetke et al., 2014) . Previous research has shown that HS has a high rate of mortality; approximately 5.8 million people in the world die from trauma every year and 50% of these cases are due to HS (Jacob and Kumar, 2014; . HS is induced by many factors, including high rate of blood loss, severe vomiting or diarrhea, intestinal obstruction, or profuse sweating. Factors that result in rapid blood loss (over 20% of whole blood) will lead to shock, and death will occur quickly when the content of blood loss accounts for more than 50% of whole blood (Bennetts et al., 2014; Williams et al., 2014) . HS is accompanied by many complications, the most evident of which is disseminated intravascular coagulation, which leads to the dysfunction of circulatory (and other internal organ) function, secondary fibrinolysis and consumptive coagulopathy. These complications will result in shock, hemorrhage, thrombosis, and hemolysis Ogaki et al., 2014) . Therefore, various means should be employed in the treatment of HS, such as ensuring airway ventilation, providing endotracheal intubation and mechanical ventilation, and conducting immediate hemostasis (Ogaki et al., 2014; Zhao et al., 2014) . Adiponectin (ADPN) has a pronounced effect on vascular endothelial function; thus, much attention has and should be paid to the relationship between ADPN and HS (Lim et al., 2014) .
ADPN, also called Acrp30, apM1, AdipoQ, and GBP28, is an important protein that exists in three forms in the serum: trimer, hexamer, and a high molecular weight form (Phillips and Kung, 2010; . ADPN possesses insulin-sensitizing, anti-inflammatory, anti-atherogenic, and antiangiogenic properties, among which the anti-inflammatory effect has been widely confirmed (Gu et al., 2013; Fiaschi et al., 2014) . Recent investigations have revealed that HS may induce hypoxia, which can result in changes in cell morphology and metabolism, concluding in an inflammatory response (Qiang et al., 2013) . In addition, hypoxia can cause sepsis, adult respiratory distress syndrome, or multiple organ dysfunctions if the severe inflammatory response persists (Fry, 2012; Lakshminarayana and Kahn, 2012) . Previous studies have shown that tumor necrosis factor-alpha (TNF-α), interleukin-1α (IL-1β), IL-6, and IL-8 play major roles in the inflammatory response after HS (Douzinas et al., 2011; Sonnier et al., 2011) . There is also evidence showing that ADPN is vital to chronic inflammation by modulating the phenotypes and functions of macrophages (Ohashi et al., 2012) . In adipose tissue, there are two types of macrophages, classic (M1) and alternative (M2), that are classified based on their expression and function of cytokines (Devaraj and Jialal, 2011) . M1 macrophages mainly secrete TNF-α, IL-1, and IL-6, while M2 macrophages can produce IL-10, an anti-inflammatory cytokine (Baker et al., 2011) . It has been found that ADPN can inhibit metalloproteinase-1 by expression of IL-10 and protect vascular injury induced by ischemia in the retina by preventing the production of TNF-α (Ohashi et al., 2012) . The present study aimed to investigate the significance of the role of ADPN in the pathophysiological processes of HS in order to provide better treatment options for HS.
MATERIAL AND METHODS

Ethics statement
All animal procedures were conducted after approval from the Medical Ethics Review Board of the Second Xiangya Hospital, Central South University (Changsha, China). Each procedure was conducted in accordance with the animal guidelines and protocols approved by the Institutional Animal Use and Care Committee. All efforts were made to minimize the number of animals used and their suffering in the study.
Grouping design
This study was conducted on 72 male C57BL/6 mice (aged 8-10 weeks; weight = 209 g) purchased from the animal laboratory at the Second Xiangya Hospital, Central South University (Changsha, China). The C57BL/6 mice were assigned randomly to three groups: 1) control group (group A, N = 24); 2) HS group (group B, N = 24, intraperitoneal anesthesia and carotid artery hemorrhage to shock); 3) recovery group (group C, N = 24, intraperitoneal anesthesia, carotid artery hemorrhage and tail vein injection of Lactated Ringer's solution for recovery).
Animal model construction
The mice in each group were anaesthetized using chloral hydrate (300 mg/kg) containing atropine by intraperitoneal injection. The mean arterial pressure (MAP) was detected by applying noninvasive blood-pressure monitors for animals (BP-98A, Softron, Japan). The right carotid artery was ligated at the distal end of the heart with cannulation using a 30-G detaining needle. The mice were exsanguinated slowly to shock while using a noninvasive blood-pressure monitor (MAP: 35 ± 5 mmHg) with the volume of hemospasia recorded. The right carotid artery was ligated following hemospasia. The left jugular vein was separated and exposed, fixed with a cannula inserted (30-G detaining needle), and connected with a micro-syringe pump (WZS-50F6, Smiths Medical Instruments, China). With the HS model constructed and the shock status maintained for 90 min, Lactated Ringer's solution was delivered at a constant speed by tail vein for 15 min. The volume of infused solution was twice that of hemospasia. After the infusion, the left jugular vein was ligated and the incision was sutured.
Hematoxylin and eosin (H&E) staining
The kidney, lung and intestinal tissue samples in groups B (24 h after hemospasia) and A were obtained and immediately fixed in 4% paraformaldehyde solution. The samples were rinsed with phosphate-buffered saline and dehydrated with ethanol. Vitrification was performed using a mixture of pure ethanol and xylene, and the samples were then immersed in paraffin. The paraffinembedded samples were cut into thick histological sections, baked, dewaxed, hydrated, stained with H&E, dehydrated with ethanol, vitrified with xylene, and sealed with gum. Finally, the stained sections were stored at room temperature.
Blood sample collection and ADPN level detection
A blood sample (500 µL) from group A was collected by tail vein after the tail cut. For group B, the blood sample (500 µL) was obtained at 4 time points (3, 6, 12, and 24 h) after the shock status was maintained for 90 min. For group C, the blood sample (500 µL) was also collected at 4 time points (3, 6, 12, and 24 h) after resuscitation. The blood samples were stored in a heparinized Eppendorf tube (1.5 mL) for further study. Samples were centrifuged at 2000 g for 5 min at 4°C, and the supernatant was placed in an Eppendorf tube and stored at -80°C. Total ADPN level in serum was measured using an enzyme-linked immunosorbent assay (ELISA) provided by Abbott (Japan).
Statistical analysis
All calculations were performed with the SPSS software (version 17.0, SPSS Inc., Chicago, IL, USA). Data are reported as means ± standard deviation. Comparisons among groups were analyzed by the Student t-test. P < 0.05 was considered significant.
RESULTS
Changes in blood pressure
After bloodletting, MAP was significantly lower in group B than in group A (32.50 ± 1.92 and 62.50 ± 3.78 mmHg, respectively; P < 0.01). For the first 30 min of HS, the blood pressure in group B showed a downward trend. After 30 min of HS, a stable hypovolemic state was observed after a slight raise in blood pressure in group B. The blood pressure of mice in group C gradually increased 90 min after treatment with Lactated Ringer's solution through the jugular vein. After the treatment (150 min), the blood pressure of mice in group C returned to levels similar to those observed in the mice in group A (Table 1 and Figure 1 ). *P < 0.05, compared with group A; # P < 0.05, compared with group B; F: a statistical value of analysis of variance. 
Pathological changes
H&E staining was conducted to detect inflammatory changes in major organs of mice in groups A and B. Figures 2, 3, and 4 show the comparison of pathological changes in kidney, lungs and intestinal tract, respectively, between groups A and B. Compared with group A, the kidney, lungs and intestinal tract of the mice in group B appeared ischemic. Under the microscope, we observed endothelial cell swelling in kidney (Figure 2) , pulmonary interstitial edema and evident inflammatory cell infiltration in lungs (Figure 3) , and intestinal mucosal injury (Figure 4 ) in the mice in group B. 
Serum ADPN levels
The ADPN levels in the peripheral blood of mice in group B were significantly higher than those in group A in the early stages of HS (3 h after bloodletting). As shown in Table 2 , ADPN levels decreased significantly with the extension of HS time (P < 0.05). In contrast with that in group B, the serum level of ADPN in group C was significantly higher in the first 3 h after recovery treatment with Lactated Ringer's solution. ADPN levels continued to increase for 24 h after recovery treatment (Table 2 and Figure 5 ). At all time points, the ADPN levels in group C were significantly higher than those in groups A and B (P < 0.05; Table 2 ). Table 2 . Adiponectin (ADPN) levels in peripheral blood of mice at different time points after shock treatment for 90 min (group B) and after recovery (group C). 
DISCUSSION
Our results show that the peripheral blood levels of ADPN in mice progressively decrease post-HS but increase after recovery treatment. It has been shown that ADPN can inhibit the production and release of TNF-α and can relieve inflammation (Jung et al., 2014; Kumpatla et al., 2014) . The primary mechanism by which ADPN inhibits inflammation is by inhibiting the production of proinflammatory cytokines and stimulating the release of anti-inflammatory cytokines (Coimbra et al., 2014; Lisowska et al., 2014) . Many studies have documented the involvement of ADPN in the termination of inflammation by at least two mechanisms: the first is through the inhibition of the function of mature macrophages and the second is the growth of granulocyte-monocyte progenitor cell lines. The former mechanism plays an important role in acute inflammation while the latter mechanism plays a major role in chronic inflammation in order to avoid excessive immune response (Antonopoulos et al., 2014; Cao et al., 2014; Li et al., 2015) . Additionally, the findings in our present study demonstrate that the serum level of ADPN in mice increase in the early period of HS, which is in accordance with the varying trend of IL-37 in the same HS model. This suggests that the transient rise of ADPN in the early stages of HS may be adaptive. In addition, the level of ADPN progressively decreased with the extension of HS time and progressively increased after the recovery treatment of HS mice. Therefore, we hypothesize that a reduction in ADPN is involved in full-body pathophysiological changes after induction of HS (Kim et al., 2014; Lian et al., 2015; Safai et al., 2015) . We found that ADPN could be used as an anti-inflammatory cytokine, which can instantly and effectively reverse HS and its concomitant pathophysiological changes in the body during post-shock recovery. Moreover, ADPN levels positively correlated with HS prognosis.
Our study showed that the expression of IL-1, IL-6, and TNF-α increased significantly in peripheral blood in the early stage of HS. IL-lβ is a proinflammatory cytokine that is involved in many pathological processes of ischemia and hypoxia, such as HS (Mishra et al., 2012) . Recent studies have shown that after induction of HS in mice, the production of monocyte macrophages leads to an increase in IL-1β levels, and it has been confirmed that HS and recovery could increase the production of IL-1β (Petrasek et al., 2012; Mishra et al., 2012) . Our study revealed that the production of IL-1β in the serum of mice remarkably increased after HS. IL-6, a common inflammatory cytokine, can directly act on vascular endothelial cells and increase their permeability, which can cause a strong inflammatory response (Neurath and Finotto, 2011; Covarrubias and Horng, 2014) . IL-6 is involved in a number of biological processes, including inflammation, oncogenesis, hematopoiesis, and immune regulation (Kishimoto, 2010) . In addition, TNF-α also plays an important role in the development of the immune system, inflammatory reactions, programmed cell death, and lipid metabolism (Horiuchi et al., 2010) . TNF-α can stimulate production of cytokines, resulting in the release of active oxygen and a variety of enzymes, and promote the aggregation and activation of granulocytes in the capillaries, which leads to inflammation and damage to tissues and organs after shock (Wu and Zhou, 2010; Li et al., 2012) . To a certain extent, the inhibition of IL-1β, IL-6, and TNF-α in early HS can inhibit further pathogenic effects of shock. After HS, the production of inflammatory factors increases rapidly, resulting in a decrease in inflammatory cytokines similar to that observed with ADPN. Following the recovery treatment of postoperative infusion of Lactated Ringer's solution, there is a decrease in the production of inflammatory factors and a progressive increase in the serum content of ADPN.
There are some notable limitations to our study. For instance, we only elucidate the relationship between ADPN serum levels and HS (and recovery) using ELISA detection in peripheral blood. Further research is needed to verify whether ADPN can be used as an index for early diagnosis and prognosis of HS. In conclusion, the changes in ADPN levels correlated with the occurrence of HS as well as the recovery from HS in mice, suggesting that ADPN could be a potential biomarker of inflammation and HS and could potentially be used in the treatment of HS.
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